1. 15 January 2013 | Global Maternal Health Conference 2013, Arusha, Tanzania

    This session focused on preterm births and how the future of this issue will be addressed. The session started with a representative from the Saving Newborn Lives initiative who gave a highlight of the situation as well as an overview of the different targets that are being set given the current situation. Jhpiego presented on the importance of prevention, management and care of preterm births. The Jhpiego presentation also included the importance of identifying potential pre-term mothers and stressed how widely-available treatments were for compounding factors that could potentially lead to pre-term births. Finally the Bill and Melinda Gates Foundation stressed the importance of antenatal steroids, which were being added to updated guidelines at that moment. The presentation also stressed that steroids provided an easy way to save a great quantity of pre-term newborns from mortality. All the presentations stressed that capacity development as well as awareness campaigns needed to be more focused upon.

    Moderator: Joel Segre, Bill & Melinda Gates Foundation

    15 million preterm births: Where, why and trends?
    Joy Lawn, Saving Newborn Lives

    Interventions for preventing and managing preterm birth
    Jeffrey Smith, Jhpiego

    Antenatal steroids for preterm birth: Rapid change is possible
    Joel Segre, Bill & Melinda Gates Foundation

    Zambia and antenatal steroids
    Elwyn Chomba, Zambian Ministry of Community Development

    # vimeo.com/58707228 Uploaded 35 Plays 0 Comments
  2. 15 January 2013 | Global Maternal Health Conference 2013, Arusha, Tanzania

    This session focused on preterm births and how the future of this issue will be addressed. The session started with a representative from the Saving Newborn Lives initiative who gave a highlight of the situation as well as an overview of the different targets that are being set given the current situation. Jhpiego presented on the importance of prevention, management and care of preterm births. The Jhpiego presentation also included the importance of identifying potential pre-term mothers and stressed how widely-available treatments were for compounding factors that could potentially lead to pre-term births. Finally the Bill and Melinda Gates Foundation stressed the importance of antenatal steroids, which were being added to updated guidelines at that moment. The presentation also stressed that steroids provided an easy way to save a great quantity of pre-term newborns from mortality. All the presentations stressed that capacity development as well as awareness campaigns needed to be more focused upon.

    Moderator: Joel Segre, Bill & Melinda Gates Foundation

    15 million preterm births: Where, why and trends?
    Joy Lawn, Saving Newborn Lives

    Interventions for preventing and managing preterm birth
    Jeffrey Smith, Jhpiego

    Antenatal steroids for preterm birth: Rapid change is possible
    Joel Segre, Bill & Melinda Gates Foundation

    Zambia and antenatal steroids
    Elwyn Chomba, Zambian Ministry of Community Development

    # vimeo.com/58972099 Uploaded 17 Plays 0 Comments
  3. 16 January 2013 | Global Maternal Health Conference 2013, Arusha, Tanzania

    This session focused on a variety of elements to make maternal health commodities accessible and available. Pembe began the session by discussing the use of uterotonic drugs in Tanzania and the knowledge and usage of these drugs in the field. His group found that knowledge of some utertonic drugs (misoprostol) was low, stock-outs were a major barrier and awareness of standard treatment guidelines were mixed. Dia decribed JSI's work in Tanzania, also on utertonics, specifically forecasting, procurement and distribution of uterotonic drugs and how to provide a secure supply chain for these medicines. They found inconsistencies for different uterotonic drugs and therefore have suggested new ways in which to keep stock of these drugs throughout the supply chain. Crapper described the work that PSI is doing around misoprostol and how they are trying to create a demand for it by using social marketing and integration into the pharmacies and private clinics. He noted that the marketing is different than other PSI programs, and therefore messages are being promoted through FP initiatives as well as making it an integral part of things women should buy for supplies for labor. The hope is that the message will get to the women where it is retained and finally acted upon. Higbie wrapped up the session by talking about VSI's work in Tanzania focusing on misoprostol and its inclusion as a uterotonic. She described some of the frustrations of trying to get it integrated, distributed and used as an essential medicine, as well as what steps are needed as a way forward, to encourage the knowledge and use of misoprostol in the future.

    Moderator: Melissa Higbie, VSI

    A framework for assessing availability of maternal health commodities: The case of misoprostol in Tanzania
    Melissa Higbie, VSI
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Higbie%201265.pdf
    Presentation: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/a_AP%20Framework_GMHC%202013%20Jan%2016.pdf

    Facilitating product introduction: From policy to practice and the role of professional medical societies
    Andrea Pembe, Muhimbili University of Health and Allied Sciences
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Pembe%201265.pdf
    Presentation: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/b_GMHC%20Presentation%20Pembe%202013%2001%2014F.pdf

    Creating the misoprostol market: Generating demand amongst providers and consumers
    Daniel Crapper, Population Services International

    Delivering essential maternal health supplies: The case of uterotonics in Tanzania
    Ousmane Dia, JSI
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Dia%201265.pdf

    # vimeo.com/60012908 Uploaded 80 Plays 0 Comments
  4. 16 January 2013 | Global Maternal Health Conference 2013, Arusha, Tanzania

    This session focused on a variety of elements to make maternal health commodities accessible and available. Pembe began the session by discussing the use of uterotonic drugs in Tanzania and the knowledge and usage of these drugs in the field. His group found that knowledge of some utertonic drugs (misoprostol) was low, stock-outs were a major barrier and awareness of standard treatment guidelines were mixed. Dia decribed JSI's work in Tanzania, also on utertonics, specifically forecasting, procurement and distribution of uterotonic drugs and how to provide a secure supply chain for these medicines. They found inconsistencies for different uterotonic drugs and therefore have suggested new ways in which to keep stock of these drugs throughout the supply chain. Crapper described the work that PSI is doing around misoprostol and how they are trying to create a demand for it by using social marketing and integration into the pharmacies and private clinics. He noted that the marketing is different than other PSI programs, and therefore messages are being promoted through FP initiatives as well as making it an integral part of things women should buy for supplies for labor. The hope is that the message will get to the women where it is retained and finally acted upon. Higbie wrapped up the session by talking about VSI's work in Tanzania focusing on misoprostol and its inclusion as a uterotonic. She described some of the frustrations of trying to get it integrated, distributed and used as an essential medicine, as well as what steps are needed as a way forward, to encourage the knowledge and use of misoprostol in the future.

    Moderator: Melissa Higbie, VSI

    A framework for assessing availability of maternal health commodities: The case of misoprostol in Tanzania
    Melissa Higbie, VSI
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Higbie%201265.pdf
    Presentation: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/a_AP%20Framework_GMHC%202013%20Jan%2016.pdf

    Facilitating product introduction: From policy to practice and the role of professional medical societies
    Andrea Pembe, Muhimbili University of Health and Allied Sciences
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Pembe%201265.pdf
    Presentation: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/b_GMHC%20Presentation%20Pembe%202013%2001%2014F.pdf

    Creating the misoprostol market: Generating demand amongst providers and consumers
    Daniel Crapper, Population Services International

    Delivering essential maternal health supplies: The case of uterotonics in Tanzania
    Ousmane Dia, JSI
    Abstract: meeting.tfigroup.com/TFI/media/uploaded/EVTFI/event_743/Dia%201265.pdf

    # vimeo.com/60006156 Uploaded 20 Plays 0 Comments
  5. 17 January 2013 | Global Maternal Health Conference 2013, Arusha, Tanzania

    Moderator: Marge Koblinsky, USAID

    Does health care financing reform increase quality and equity in maternal health services? A study in Ethiopia
    Devi Nair, Jimma University, Ethiopia

    Improving health worker performance using a voucher system in eastern Uganda
    John Bua, Makerere University School of Public Health

    Community participation for improved quality for maternal, newborn and child health care
    Emmanuel Kenyi, Africa Medical and Research Foundation, South Sudan

    Financial incentives to improve quality of maternal care? Current evidence and future needs
    Kathleen Hill, USAID Health Care Improvement Project, University Research Company

    # vimeo.com/58893834 Uploaded 12 Plays 0 Comments

Strengthening health systems for improving the quality of maternal health care

Maternal Health Task Force PRO

Browse This Channel

Shout Box

Heads up: the shoutbox will be retiring soon. It’s tired of working, and can’t wait to relax. You can still send a message to the channel owner, though!

Channels are a simple, beautiful way to showcase and watch videos. Browse more Channels.